Upside – $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) – $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) – $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) – $QSI +13% (no clear fresh catalyst identified; unusually large move …
Read in context ›Rocket Lab USA Stock (RKLB)
Track Rocket Lab USA stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
Read the latest TheStreet Pro articles mentioning Rocket Lab USA, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
266 articlesDaily Diary Mentions
13 mentionsUpside, Downside Movers in the Morning Positive Chart Development On Thursday (yesterday) morning, I wrote to the "Stocks Under $10" crowd and cautioned that one of my core holdings, Rocket Lab USA ( RKLB ) , could be developing a head-and-shoulders pattern of bearish reversal. I wrote…
Read in context ›Heads Up on Rocket Lab Let's talk about Rocket Lab ( RKLB ) . For those who do not follow my other work around TheStreet Pro, Rocket Lab is one of our huge success stories at "Stocks Under $10." This name is core to both that series and my own…
Read in context ›Space Command On Wednesday, President Trump signed an executive order that will ease regulation for commercial spaceflight. The statement released by the White House notes, "Inefficient permitting processes discourage investment and i…
Read in context ›Taking Some Profits With the probability for something dovish from Fed Chair Jerome Powell rightfully diminished next week, I am taking some profits across Peloton Interactive PTON , though my target price remains $9. I am also making sales…
Read in context ›




